Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donghui Xing

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|January 23, 2017
An adaptive method for determining an acquisition parameter t<sub>0</sub> in a modified CPMG sequenceDonghui Xing, Yiren Fan, Jianfei Hao, et al.
Frontiers in Immunology|August 18, 2025
SUMOylation-related genes define prognostic subtypes in stomach adenocarcinoma: integrating single-cell analysis and machine learning analysesKaiping Luo, Donghui Xing, Xiang He, et al.
Organic Letters|February 15, 2024
1,2,3-Thiadiazole as a Modifiable and Scalable Directing Group for <i>ortho</i>-C-H FunctionalizationXiaoyan Jia, Donghui Xing, Jiayi Shen, et al.
Biomedicines|October 29, 2025
Programmed-Cell-Death-Related Signature Reveals Immune Microenvironment Characteristics and Predicts Therapeutic Response in Diffuse Large B Cell LymphomaDonghui Xing, Kaiping Luo, Xiang He, et al.
Annals of Hematology|April 9, 2025
Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patientsYaoyao Jing, Donghui Xing, Bo Yang, et al.
Tumori|April 5, 2019
Clinical characteristics and prognosis associated with multiple primary malignant tumors in non-Hodgkin lymphoma patientsYanan Jiang, Zhaoyi Miao, Jinhuan Wang, et al.
Current Molecular Medicine|January 16, 2026
A Cuproptosis-related lncRNA Signature for Prognostic Stratification and Immunotherapeutic Implications in Lung AdenocarcinomaYanan Jiang, Donghui Xing, Kaiping Luo, et al.
Cell Death Discovery|May 1, 2024
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemiaWenqi Wu, Yanan Jiang, Donghui Xing, et al.
Oncology Letters|May 9, 2020
Characteristics of myeloid sarcoma in mice and patients with <i>TET2</i> deficiencyJinhuan Wang, Zhaoyi Miao, Yanan Jiang, et al.
Oncology Letters|August 18, 2020
Erratum: Characteristics of myeloid sarcoma in mice and patients with TET2 deficiencyJinhuan Wang, Zhaoyi Miao, Yanan Jiang, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|January 23, 2017
An adaptive method for determining an acquisition parameter t<sub>0</sub> in a modified CPMG sequenceDonghui Xing, Yiren Fan, Jianfei Hao, et al.
Frontiers in Immunology|August 18, 2025
SUMOylation-related genes define prognostic subtypes in stomach adenocarcinoma: integrating single-cell analysis and machine learning analysesKaiping Luo, Donghui Xing, Xiang He, et al.
Organic Letters|February 15, 2024
1,2,3-Thiadiazole as a Modifiable and Scalable Directing Group for <i>ortho</i>-C-H FunctionalizationXiaoyan Jia, Donghui Xing, Jiayi Shen, et al.
Biomedicines|October 29, 2025
Programmed-Cell-Death-Related Signature Reveals Immune Microenvironment Characteristics and Predicts Therapeutic Response in Diffuse Large B Cell LymphomaDonghui Xing, Kaiping Luo, Xiang He, et al.
Annals of Hematology|April 9, 2025
Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patientsYaoyao Jing, Donghui Xing, Bo Yang, et al.
Tumori|April 5, 2019
Clinical characteristics and prognosis associated with multiple primary malignant tumors in non-Hodgkin lymphoma patientsYanan Jiang, Zhaoyi Miao, Jinhuan Wang, et al.
Current Molecular Medicine|January 16, 2026
A Cuproptosis-related lncRNA Signature for Prognostic Stratification and Immunotherapeutic Implications in Lung AdenocarcinomaYanan Jiang, Donghui Xing, Kaiping Luo, et al.
Cell Death Discovery|May 1, 2024
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemiaWenqi Wu, Yanan Jiang, Donghui Xing, et al.
Oncology Letters|May 9, 2020
Characteristics of myeloid sarcoma in mice and patients with <i>TET2</i> deficiencyJinhuan Wang, Zhaoyi Miao, Yanan Jiang, et al.
Oncology Letters|August 18, 2020
Erratum: Characteristics of myeloid sarcoma in mice and patients with TET2 deficiencyJinhuan Wang, Zhaoyi Miao, Yanan Jiang, et al.
Pageof 3